Navigating the Transition to a Higher-Acuity, Asset-Light Healthcare Platform

Tenet Healthcare Corporation is a diversified healthcare services company. Following a significant portfolio transformation, the company now operates through two primary segments: Hospital Operations and Ambulatory Care (via USPI).

• Hospital Operations: Tenet owns and operates a network of acute-care hospitals and related facilities in select, high-growth urban and suburban markets across the United States. These hospitals provide a full range of services, including emergency, surgical, and diagnostic care. The company has focused on retaining hospitals in markets with strong demographics, favorable payer mixes, and opportunities for service-line expansion.

• Ambulatory Care (USPI): USPI is the nation's largest independent ambulatory surgery center platform. It develops, acquires, and operates ASCs in partnership with physicians and health systems. USPI provides a full suite of surgical services across multiple specialties, including orthopedics, gastroenterology, ophthalmology, and pain management. This segment is the primary driver of the company's growth and profitability.

How it makes money: The company generates revenue through patient care services, primarily from negotiated rates with commercial payers, government programs (Medicare and Medicaid), and other third-party payers. The ambulatory segment's earnings are driven by case volumes and its fee-for-service model, while the hospital segment's earnings are tied to patient admissions and outpatient visits.

Customers and Scale: Tenet's customers are patients, physicians, health plans, and employers. As of the latest reporting period, the company operates approximately 50 acute-care hospitals and over 480 ambulatory surgery centers, serving millions of patients annually. The company employs over 100,000 people.

• Near-Term Growth Drivers: The primary near-term driver is continued volume growth at USPI, propelled by the ongoing shift of procedures to outpatient settings, strong physician recruitment, and the maturation of recently opened de novo centers. The hospital segment is expected to see stable, low-single-digit volume growth, supplemented by rate increases and continued cost discipline.

• Medium-Term Growth Drivers: The medium-term outlook is anchored by a robust pipeline of new ASC development projects and strategic tuck-in acquisitions that expand USPI's geographic reach and service offerings. Additionally, the company is focused on growing its higher-acuity service lines (e.g., total joints and spine) within its ASCs, which command higher reimbursement and present a significant market opportunity. Management has guided to a multi-year target of high-single-digit to low-double-digit adjusted EBITDA growth, with USPI growing at a faster clip.

Note: Figures are illustrative estimates based on the company's trajectory and reported EPS of $25.88.

The company's financial profile has improved dramatically, driven by the divestiture of lower-margin hospital assets and the increasing revenue mix from the high-margin ambulatory segment. This has resulted in significant adjusted EBITDA margin expansion, from roughly 16% in 2023 to a projected 22.7% in 2026. The substantial increase in adjusted EPS reflects strong operational performance, a lower share count from buybacks, and the beneficial impact of a lower tax rate. The core driver remains USPI, which is expected to contribute over 60% of total adjusted EBITDA by 2026.

The U.S. healthcare services market is massive, with an estimated TAM exceeding $4 trillion. The ambulatory surgery center market is a high-growth subset, estimated at over $40 billion and projected to grow at a mid-single-digit to high-single-digit CAGR, driven by volume migration, technological advancements, and payer initiatives to lower costs.

Tenet is the clear leader in the ASC space through USPI, with the largest independent platform. Key competitors in the ASC market include Surgery Partners (SGRY) and Envision Healthcare, while HCA Healthcare (HCA) and Universal Health Services (UHS) are the primary investor-owned hospital comparables. Tenet's competitive positioning is unique—it offers a diversified model of both hospitals and ASCs, allowing it to capture value across the care continuum. USPI's scale provides advantages in contracting, supply chain, and best-practice sharing that smaller competitors cannot match.

Valuation is based on a blend of forward EV/EBITDA and discounted cash flow (DCF) analysis. The company is currently trading at a meaningful discount to its hospital peers on forward EV/EBITDA, despite having a faster-growing, higher-quality ambulatory mix.

Comparable Company Multiples (Forward EV/EBITDA):

A DCF analysis, using a WACC of approximately 9% and a terminal growth rate of 3%, and incorporating the company's projected free cash flow growth, yields an intrinsic value in the range of $300-$320 per share. This implies that the current share price of $269.70 does not fully reflect the company's growth potential and the quality of its earnings stream.

• Regulatory and Reimbursement Risk: Changes to government healthcare programs (Medicare/Medicaid) or commercial payer policies could negatively impact reimbursement rates for both ASCs and hospitals. Any adverse legislation or rate cuts would directly pressure revenue and margins.

• Integration and Execution Risk: The company's growth strategy relies heavily on the successful execution of its de novo pipeline and the integration of acquisitions. Delays, cost overruns, or poor performance at acquired facilities could impede growth and harm returns.

• Volume and Utilization Risk: A slowdown in elective surgical procedures due to an economic downturn, a public health crisis, or shifts in patient behavior could significantly impact volumes, particularly in the higher-margin ambulatory segment, which is more sensitive to discretionary procedures.

• Labor and Cost Inflation: The healthcare industry continues to face significant labor shortages and wage inflation, particularly for nurses and clinical staff. While the ambulatory model is less labor-intensive, persistent cost pressures could compress margins across both segments.

• Competitive Dynamics: The ASC market is becoming increasingly competitive, with health systems and other national players like Surgery Partners aggressively expanding. This could lead to increased competition for physician partners, favorable real estate, and payer contracts, potentially limiting growth or lowering returns.